{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:29:17Z","timestamp":1758709757494},"reference-count":55,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[1999,2,1]],"date-time":"1999-02-01T00:00:00Z","timestamp":917827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[1999,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            In vivo passage of a poorly replicating, nonpathogenic simian-human immunodeficiency virus (SHIV-HXBc2) generated an efficiently replicating virus, KU-1, that caused rapid CD4\n            <jats:sup>+<\/jats:sup>\n            T-lymphocyte depletion and AIDS-like illness in monkeys (S. V. Joag, Z. Li, L. Foresman, E. B. Stephens, L.-J. Zhao, I. Adany, D. M. Pinson, H. M. McClure, and O. Narayan, J. Virol. 70:3189\u20133197, 1996). The\n            <jats:italic>env<\/jats:italic>\n            gene of the KU-1 virus was used to create a molecularly cloned virus, SHIV-HXBc2P 3.2, that differed from a nonpathogenic SHIV-HXBc2 virus in only 12 envelope glycoprotein residues. SHIV-HXBc2P 3.2 replicated efficiently and caused rapid and persistent CD4\n            <jats:sup>+<\/jats:sup>\n            T-lymphocyte depletion in inoculated rhesus macaques. Compared with the envelope glycoproteins of the parental SHIV-HXBc2, the SHIV-HXBc2P 3.2 envelope glycoproteins supported more efficient infection of rhesus monkey peripheral blood mononuclear cells. Both the parental SHIV-HXBc2 and the pathogenic SHIV-HXBc2P 3.2 used CXCR4 but none of the other seven transmembrane segment receptors tested as a second receptor. Compared with the parental virus, viruses with the SHIV-HXBc2P 3.2 envelope glycoproteins were more resistant to neutralization by soluble CD4 and antibodies. Thus, changes in the envelope glycoproteins account for the ability of the passaged virus to deplete CD4\n            <jats:sup>+<\/jats:sup>\n            T lymphocytes rapidly and specify increased replicative capacity and resistance to neutralization.\n          <\/jats:p>","DOI":"10.1128\/jvi.73.2.976-984.1999","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T18:22:49Z","timestamp":1577816569000},"page":"976-984","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":81,"title":["Changes in Human Immunodeficiency Virus Type 1 Envelope Glycoproteins Responsible for the Pathogenicity of a Multiply Passaged Simian-Human Immunodeficiency Virus (SHIV-HXBc2)"],"prefix":"10.1128","volume":"73","author":[{"given":"Mark","family":"Cayabyab","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Department of Cancer Immunology\/AIDS, Dana-Farber Cancer Institute, Department of Pathology1 and"},{"name":"<!--label omitted: 2-->Department of Immunology and Infectious Diseases, Harvard School of Public Health,2 Boston, Massachusetts 02115, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunilla B.","family":"Karlsson","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Cancer Immunology\/AIDS, Dana-Farber Cancer Institute, Department of Pathology1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijan A.","family":"Etemad-Moghadam","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Cancer Immunology\/AIDS, Dana-Farber Cancer Institute, Department of Pathology1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Hofmann","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Cancer Immunology\/AIDS, Dana-Farber Cancer Institute, Department of Pathology1 and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tavis","family":"Steenbeke","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center,3 Harvard Medical School, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matilda","family":"Halloran","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center,3 Harvard Medical School, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Fanton","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->Oregon Regional Primate Research Center, Beaverton, Oregon 97006-34994"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael K.","family":"Axthelm","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->Oregon Regional Primate Research Center, Beaverton, Oregon 97006-34994"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman L.","family":"Letvin","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Division of Viral Pathogenesis, Beth Israel Deaconess Medical Center,3 Harvard Medical School, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph G.","family":"Sodroski","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Department of Cancer Immunology\/AIDS, Dana-Farber Cancer Institute, Department of Pathology1 and"},{"name":"<!--label omitted: 2-->Department of Immunology and Infectious Diseases, Harvard School of Public Health,2 Boston, Massachusetts 02115, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5270.1955"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6189183"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/382829a0"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.5.1925"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.1.166-171.1995"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7973652"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.1.305-309.1992"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.2.1301-1309.1996"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.11.5782-5789.1991"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81313-6"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2425430"},{"key":"e_1_3_2_13_2","first-page":"64","article-title":"Use of eukaryotic expression technology in the functional analysis of clones genes","volume":"152","author":"Cullen B. R.","year":"1989","unstructured":"Cullen B. R. Use of eukaryotic expression technology in the functional analysis of clones genes.Methods Enzymol. 152 1989 64 73","journal-title":"Methods Enzymol."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1038\/381661a0"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81314-8"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/381667a0"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.3.405"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-100-1-92"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.272.5263.872"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.4.2779-2785.1997"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.6200936"},{"key":"e_1_3_2_22_2","unstructured":"Hayami M. and T. Igarashi. 1997. SIV\/HIV-1 chimeric viruses having HIV-1 env gene: a new animal model and a candidate for attenuated live vaccine. Leukemia 11 (Suppl. 3):95\u201397."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.64.5.2416-2420.1990"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/373123a0"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.5.3189-3197.1996"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.6.4218-4225.1997"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.4.2253-2259.1994"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(90)90127-U"},{"key":"e_1_3_2_29_2","first-page":"639","article-title":"Infection of cynomolgus monkeys with a chimeric HIV-1\/SIVmac virus that expresses the HIV-1 envelope glycoproteins","volume":"5","author":"Li J.","year":"1992","unstructured":"Li J. Lord C. I. Haseltine W. Letvin N. L. Sodroski J. Infection of cynomolgus monkeys with a chimeric HIV-1\/SIVmac virus that expresses the HIV-1 envelope glycoproteins.J. Acquired Immune Defic. Syndr. 5 1992 639 646","journal-title":"J. Acquired Immune Defic. Syndr."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.11.7061-7067.1995"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.185.11.2015"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.16.7490"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.3.2522-2527.1997"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.1.101-109.1995"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.4.2067-2075.1992"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.10.7518-7525.1997"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/348069a0"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/382833a0"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199702000-00006"},{"key":"e_1_3_2_40_2","first-page":"7","article-title":"Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120","volume":"67","author":"Posner M. R.","year":"1993","unstructured":"Posner M. R. Cavacini L. A. Emes C. L. Power J. Byrn R. Neutralization of HIV-1 by F105, a human monoclonal antibody to the CD4 binding site of gp120.J. Acquired Immune Defic. Syndr. 67 1993 7 14","journal-title":"J. Acquired Immune Defic. Syndr."},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.10.6922-6928.1996"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.5.3198-3206.1996"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990170113"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.1.185"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.4.2588-2593.1992"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/349167a0"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.20.9434"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/322470a0"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.8.4973-4979.1994"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0684.1996.tb00014.x"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1997.8534"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.8.6332-6338.1998"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.7.4413-4422.1995"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.2.674-680.1994"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.9.5635-5641.1992"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.8.3097"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.73.2.976-984.1999","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.73.2.976-984.1999","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T03:29:37Z","timestamp":1646450977000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.73.2.976-984.1999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,2]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,2]]}},"alternative-id":["10.1128\/JVI.73.2.976-984.1999"],"URL":"https:\/\/doi.org\/10.1128\/jvi.73.2.976-984.1999","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,2]]},"assertion":[{"value":"1998-07-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1998-10-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-02-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}